JP2016513472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513472A5 JP2016513472A5 JP2016502468A JP2016502468A JP2016513472A5 JP 2016513472 A5 JP2016513472 A5 JP 2016513472A5 JP 2016502468 A JP2016502468 A JP 2016502468A JP 2016502468 A JP2016502468 A JP 2016502468A JP 2016513472 A5 JP2016513472 A5 JP 2016513472A5
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- cell population
- cells
- pge2
- contacted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361792818P | 2013-03-15 | 2013-03-15 | |
| US61/792,818 | 2013-03-15 | ||
| PCT/US2014/027521 WO2014152603A1 (en) | 2013-03-15 | 2014-03-14 | Stem cell culture media and methods of enhancing cell survival |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020000736A Division JP2020089373A (ja) | 2013-03-15 | 2020-01-07 | 幹細胞培養培地及び細胞生存を増強する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016513472A JP2016513472A (ja) | 2016-05-16 |
| JP2016513472A5 true JP2016513472A5 (https=) | 2017-04-20 |
Family
ID=51581254
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502468A Pending JP2016513472A (ja) | 2013-03-15 | 2014-03-14 | 幹細胞培養培地及び細胞生存を増強する方法 |
| JP2020000736A Pending JP2020089373A (ja) | 2013-03-15 | 2020-01-07 | 幹細胞培養培地及び細胞生存を増強する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020000736A Pending JP2020089373A (ja) | 2013-03-15 | 2020-01-07 | 幹細胞培養培地及び細胞生存を増強する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9943545B2 (https=) |
| EP (1) | EP2970894A4 (https=) |
| JP (2) | JP2016513472A (https=) |
| CN (1) | CN105358679A (https=) |
| AU (1) | AU2014239290B2 (https=) |
| CA (1) | CA2906641C (https=) |
| WO (1) | WO2014152603A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2760994T (pt) * | 2011-09-30 | 2017-08-24 | Bluebird Bio Inc | Compostos para melhor transdução viral |
| KR20170115514A (ko) | 2014-12-30 | 2017-10-17 | 셀 큐어 뉴로사이언시스 리미티드 | Rpe 세포 집단 및 이를 생성하는 방법 |
| AU2016211671B2 (en) | 2015-01-26 | 2022-05-26 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2016120891A1 (en) * | 2015-01-30 | 2016-08-04 | Coral Drugs Pvt. Ltd. | Novel process for preparation of glucocorticoid steroids |
| RU2018106515A (ru) | 2015-07-21 | 2019-08-21 | Зе Чилдрен'С Медикал Сентер Корпорейшн | Pd-l1-экспрессирующие гемопоэтические стволовые клетки и применения |
| JP6928604B2 (ja) | 2015-11-04 | 2021-09-01 | フェイト セラピューティクス，インコーポレイテッド | 万能性細胞のゲノム改変 |
| CA3003152A1 (en) | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| CN105713880A (zh) * | 2016-04-20 | 2016-06-29 | 广东艾时代生物科技有限责任公司 | 一种造血干细胞体外扩增培养的无血清培养基及其应用 |
| CN105749252B (zh) * | 2016-04-29 | 2025-11-14 | 南方医科大学 | Il-9作为治疗血小板缺少症的药物的应用 |
| US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| US10426796B2 (en) | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| CN106434549A (zh) * | 2016-12-20 | 2017-02-22 | 江西宜信堂医疗科技有限公司 | 一种无血清干细胞培养基及其制备方法 |
| KR102018609B1 (ko) * | 2017-04-26 | 2019-09-06 | 이장호 | 중간엽 줄기세포 배양액을 포함하는 세포 또는 조직의 동결보존용 조성물 |
| WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
| BR112020013238A2 (pt) * | 2017-12-29 | 2020-12-01 | Cell Cure Neurosciences Ltd. | composição e método para formular células do epitélio pigmentar da retina bem como uso da dita composição para tratar uma condição retiniana |
| JP7036670B2 (ja) * | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
| CN110894490A (zh) * | 2018-09-13 | 2020-03-20 | 李陶 | 一种脐带造血干细胞体外扩增培养体系和脐带造血干细胞体外扩增方法 |
| IL282563B2 (en) * | 2018-10-24 | 2025-05-01 | Hebecell Corp | Methods and systems for producing lineage cells involved in the formation of blood cells |
| CA3130698A1 (en) * | 2019-03-18 | 2020-09-24 | Steven John GRECO | Methods and clinical protocols and kits pertaining to making and using therapeutic compositions for cellular treatment |
| CN110317782B (zh) * | 2019-07-18 | 2023-06-13 | 天津瑞博斯生物技术有限公司 | 提高间充质干细胞复苏后存活的方法和所用的冻存液 |
| CN112779209B (zh) * | 2019-11-08 | 2023-01-24 | 合肥中科普瑞昇生物医药科技有限公司 | 原代乳腺上皮细胞培养基、培养方法及其应用 |
| CN110923194B (zh) * | 2019-12-23 | 2021-08-13 | 广东依浦赛生物科技有限公司 | 一种原代细胞培养的方法 |
| TWI888659B (zh) * | 2021-10-13 | 2025-07-01 | 芯芮生技開發股份有限公司 | 幹細胞條件培養基於製備抑制癌症組成物的用途 |
| CN116889226A (zh) * | 2022-04-02 | 2023-10-17 | 杭州启函生物科技有限公司 | Nk细胞冻存液 |
| CN119300846A (zh) * | 2022-06-03 | 2025-01-10 | 蓝岩治疗有限公司 | 细胞递送媒介物及其使用方法 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
| US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
| US5405772A (en) | 1993-06-18 | 1995-04-11 | Amgen Inc. | Medium for long-term proliferation and development of cells |
| US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| EP0891419A4 (en) | 1996-03-12 | 2000-03-01 | Life Technologies Inc | NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES |
| PL335227A1 (en) | 1997-02-20 | 2000-04-10 | Dsm Nv | Industrial-scale production of valuable compounds by fermentation in a chemically defined medium |
| US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| JP2000201672A (ja) * | 1999-01-11 | 2000-07-25 | Asahi Medical Co Ltd | 有核細胞の凍結保存用組成物 |
| AU770867B2 (en) | 1999-08-13 | 2004-03-04 | Fumie Sato | Prostaglandin derivatives |
| IL141120A0 (en) | 2000-01-31 | 2002-02-10 | Pfizer Prod Inc | Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US7968329B2 (en) * | 2000-10-06 | 2011-06-28 | Michael Dancu | Method of conditioning a hybrid synthetic tubular structure to yield a functional human hybrid coronary bypass graft |
| JP2003225084A (ja) | 2000-12-28 | 2003-08-12 | Japan Science & Technology Corp | 凍結細胞保存剤 |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| EP1458854B1 (en) | 2001-12-21 | 2010-04-14 | Mount Sinai Hospital | Cellular compositions and methods of making and using them |
| US7176022B2 (en) * | 2002-12-20 | 2007-02-13 | Cell Genesys, Inc. | Directly injectable formulations which provide enhanced cryoprotection of cell products |
| US6747037B1 (en) | 2003-06-06 | 2004-06-08 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| AU2005299473B2 (en) | 2004-10-26 | 2012-06-28 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin EP4 agonists |
| US20060193839A1 (en) | 2005-02-28 | 2006-08-31 | Donnie Rudd | Method of providing readily available cellular material derived from peripheral blood, and a composition thereof |
| AU2006252363A1 (en) | 2005-06-02 | 2006-12-07 | Stemcyte, Inc. | Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use |
| DE102005062741A1 (de) | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| EP3424507A1 (en) | 2006-03-24 | 2019-01-09 | Children's Medical Center Corporation | Method to modulate hematopoietic stem cell growth |
| WO2008034803A1 (en) * | 2006-09-18 | 2008-03-27 | Medizinische Universität Graz | Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
| EP2679221B1 (en) | 2006-10-20 | 2020-09-23 | Children's Medical Center Corporation | Method to enhance tissue regeneration |
| US9394520B2 (en) | 2006-12-08 | 2016-07-19 | University Of Rochester | Expansion of hematopoietic stem cells |
| KR20200011604A (ko) | 2008-08-20 | 2020-02-03 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
| PT3031907T (pt) * | 2008-11-06 | 2021-01-28 | Univ Indiana Res & Tech Corp | Materiais e métodos para melhorar procedimentos de enxerto de células estaminais hematopoiéticas |
| EP2408444A4 (en) | 2009-03-19 | 2012-09-26 | Fate Therapeutics Inc | COMPOSITIONS WITH CYCLIC AMP AMPLIFIERS AND / OR EP LIGANDS, AND METHOD FOR THEIR PRODUCTION AND USE |
| AU2010251151B2 (en) | 2009-05-20 | 2015-08-20 | Cardio3 Biosciences S.A. | Pharmaceutical Composition for the Treatment of Heart Diseases |
| US11459545B2 (en) | 2009-11-15 | 2022-10-04 | Indiana University Research And Technology Corporation | Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin E2 receptors |
| JP5773347B2 (ja) * | 2009-11-27 | 2015-09-02 | 国立大学法人 千葉大学 | 血液細胞の凍結保存剤 |
| EP2603227B1 (en) | 2010-08-12 | 2017-10-04 | Fate Therapeutics, Inc. | Improved hematopoietic stem and progenitor cell therapy |
| TWI535377B (zh) * | 2011-09-01 | 2016-06-01 | Storage, culture and application of umbilical cord tissue and its derived cells | |
| WO2013055476A1 (en) * | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
| EP3785767A1 (en) | 2011-12-02 | 2021-03-03 | Fate Therapeutics, Inc. | Enhanced stem cell composition |
| US10111907B2 (en) | 2011-12-02 | 2018-10-30 | Fate Therapeutics, Inc. | Methods of treating ischemia |
| US10851412B2 (en) | 2013-03-15 | 2020-12-01 | Fate Therapeutics, Inc. | Cell potency assay for therapeutic potential |
-
2014
- 2014-03-13 US US14/209,131 patent/US9943545B2/en active Active
- 2014-03-14 AU AU2014239290A patent/AU2014239290B2/en not_active Ceased
- 2014-03-14 CN CN201480027789.8A patent/CN105358679A/zh active Pending
- 2014-03-14 EP EP14767366.9A patent/EP2970894A4/en not_active Withdrawn
- 2014-03-14 JP JP2016502468A patent/JP2016513472A/ja active Pending
- 2014-03-14 WO PCT/US2014/027521 patent/WO2014152603A1/en not_active Ceased
- 2014-03-14 CA CA2906641A patent/CA2906641C/en active Active
-
2018
- 2018-03-07 US US15/914,836 patent/US11135244B2/en not_active Expired - Fee Related
-
2020
- 2020-01-07 JP JP2020000736A patent/JP2020089373A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016513472A5 (https=) | ||
| JP2020089373A5 (https=) | ||
| AU2022291632B2 (en) | Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response | |
| US11162075B2 (en) | Methods and compositions for inducing hematopoietic cell differentiation | |
| Bao et al. | Chemically-defined albumin-free differentiation of human pluripotent stem cells to endothelial progenitor cells | |
| Zuk | Adipose‐derived stem cells in tissue regeneration: a review | |
| US9074176B2 (en) | Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof | |
| Jung et al. | Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells | |
| KR101138091B1 (ko) | 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제 | |
| JP6636427B2 (ja) | 小分子を用いるヒト多能性幹細胞からの内分泌始原細胞の作製 | |
| Sart et al. | Process engineering of stem cell metabolism for large scale expansion and differentiation in bioreactors | |
| JP6949336B2 (ja) | 人工多能性幹細胞由来腸管幹細胞の維持培養 | |
| WO2018143258A1 (ja) | 多分化能性幹細胞増殖促進剤 | |
| Koellensperger et al. | Choosing the right type of serum for different applications of human adipose tissue–derived stem cells: Influence on proliferation and differentiation abilities | |
| CN105358679A (zh) | 干细胞培养基和增加细胞存活的方法 | |
| CN112961825B (zh) | 一种无血清培养基及其制备方法 | |
| TW200927927A (en) | Stem cell medium | |
| CN108060126B (zh) | 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合 | |
| Tarle et al. | Development of a serum‐free system to expand dental‐derived stem cells: PDLSCs and SHEDs | |
| Yagi Mendoza et al. | Regeneration of insulin-producing islets from dental pulp stem cells using a 3D culture system | |
| JP2020014477A (ja) | 膵島様細胞構造体及びそれを調製する方法 | |
| CN111607556B (zh) | 一种培养扩增人肝祖细胞的培养基及其应用 | |
| US20230002729A1 (en) | Cell culture medium composition | |
| EP3792345A1 (en) | Method for promoting differentiation of pluripotent stem cells | |
| WO2024113352A1 (en) | Methods and compositions for differentiation of pluripotent stem cells and derived hematopoietic lineage cells |